GeoVax prices USD 3 million private placement at-the-market under Nasdaq rules

• GeoVax Labs priced a USD 3 million private placement with existing institutional investors, selling 2,027,027 common shares or equivalents at-the-market under Nasdaq rules.
• The deal includes Series A warrants for up to 2,027,027 shares with a USD 1.48 exercise price and a five-year term, plus Series B warrants for up to 2,027,027 shares with a USD 1.48 exercise price and an 18-month term.
• Closing is expected on or about May 19, 2026, subject to customary conditions.
• Proceeds are slated for working capital and general corporate purposes.
• A.G.P./Alliance Global Partners is sole placement agent.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GeoVax Labs Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-017809), on May 19, 2026, and is solely responsible for the information contained therein.